Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
The Journal of Endocrinology
|
June 1, 2000
The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
J Svensson, S Lall, S L Dickson, et al.
Endocrine
|
April 27, 2001
Effects of growth hormone and its secretagogues on bone
J Svensson, S Lall, S L Dickson, et al.
International Journal of Obesity (2005)
|
March 18, 2009
Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men
N Andersson, L Strandberg, S Nilsson, et al.
Journal of Neuroendocrinology
|
October 13, 2017
Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle
F Anesten, C Santos, E Gidestrand, et al.
The Journal of Endocrinology
|
May 30, 2006
Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice
J Svensson, M Diez, J Engel, et al.
Acta Paediatrica Scandinavica. Supplement
|
January 11, 1990
Pulsatile growth hormone secretory pattern: autofeedback regulation and effects on growth factors
J O Jansson, L Carlsson, S Ekberg, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
August 11, 2004
A common polymorphism in the interleukin-6 gene promoter is associated with overweight
I Wernstedt, A-L Eriksson, A Berndtsson, et al.
Journal of the International AIDS Society
|
November 14, 2014
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143
Juan Berenguer, Ferdinand Wit, Per O Jansson, et al.
Oncogene
|
June 8, 1999
Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas
K Helou, V Wallenius, Y Qiu, et al.
Primary Care Diabetes
|
June 14, 2020
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe
S Seidu, X Cos, S Brunton, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
The Journal of Endocrinology
|
June 1, 2000
The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats
J Svensson, S Lall, S L Dickson, et al.
Endocrine
|
April 27, 2001
Effects of growth hormone and its secretagogues on bone
J Svensson, S Lall, S L Dickson, et al.
International Journal of Obesity (2005)
|
March 18, 2009
Variants of the interleukin-1 receptor antagonist gene are associated with fat mass in men
N Andersson, L Strandberg, S Nilsson, et al.
Journal of Neuroendocrinology
|
October 13, 2017
Functional interleukin-6 receptor-α is located in tanycytes at the base of the third ventricle
F Anesten, C Santos, E Gidestrand, et al.
The Journal of Endocrinology
|
May 30, 2006
Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice
J Svensson, M Diez, J Engel, et al.
Acta Paediatrica Scandinavica. Supplement
|
January 11, 1990
Pulsatile growth hormone secretory pattern: autofeedback regulation and effects on growth factors
J O Jansson, L Carlsson, S Ekberg, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
August 11, 2004
A common polymorphism in the interleukin-6 gene promoter is associated with overweight
I Wernstedt, A-L Eriksson, A Berndtsson, et al.
Journal of the International AIDS Society
|
November 14, 2014
Acceptance rate of clinical study endpoints and adequacy of source documentation: experience from clinical study endpoint review in NEAT001/ANRS143
Juan Berenguer, Ferdinand Wit, Per O Jansson, et al.
Oncogene
|
June 8, 1999
Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas
K Helou, V Wallenius, Y Qiu, et al.
Primary Care Diabetes
|
June 14, 2020
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe
S Seidu, X Cos, S Brunton, et al.
Page
of 15